Celldex Therapeutics CLDX
NASDAQ CLDX
$31.65 +0.16 (+0.51%)
As of: Sep 29, 2026 · 3:59 PM EDT

Celldex Therapeutics (CLDX) Operating Expenses (2010 - 2026)

Updated

Celldex Therapeutics (CLDX) reported Operating Expenses of $80.65 million for Q2 2026, up 24.9% from $64.59 million a year earlier but down 4.5% from the prior quarter.

Analysis

Celldex Therapeutics (CLDX) Operating Expenses (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Celldex Therapeutics' Operating Expenses came in at $325.99 million, up 35.5% year-over-year; for FY2025, it came in at $288.91 million, up 43.0% from FY2024.

  • Operating Expenses has increased for six consecutive years, with a five-year compound annual growth rate of 32.5% (FY2020 to FY2025).
  • By year, Operating Expenses came in at $202.1 million in FY2024 (+25.2%), $161.43 million in FY2023 (+37.3%), $117.59 million in FY2022 (+54.9%) and $75.89 million in FY2021 (+7.2%).
  • Five-year quarterly Operating Expenses spans a low of $20.67 million in Q4 2021 and a high of $87.27 million in Q4 2025.
  • Year over year, Operating Expenses has now increased in each of the last 12 quarters, with growth averaging 33.9% over the last eight quarters.
  • The high point for year-over-year Operating Expenses in five years was Q2 2022 (growth of 116.1%); the low point was Q4 2021 (a decline of 27.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $84.45 million (Q1 2026), $87.27 million (Q4 2025) and $73.62 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Celldex Therapeutics 2.47 Bn 2.47 Bn - 80.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 80.65 Mn
Mar 31, 2026 84.45 Mn
Dec 31, 2025 87.27 Mn
Sep 30, 2025 73.62 Mn
Jun 30, 2025 64.59 Mn
Mar 31, 2025 63.43 Mn
Dec 31, 2024 57.20 Mn
Sep 30, 2024 55.32 Mn
Jun 30, 2024 48.82 Mn
Mar 31, 2024 40.76 Mn
Dec 31, 2023 51.76 Mn
Sep 30, 2023 42.76 Mn
Jun 30, 2023 33.47 Mn
Mar 31, 2023 33.44 Mn
Dec 31, 2022 29.50 Mn
Sep 30, 2022 28.10 Mn
Jun 30, 2022 36.56 Mn
Mar 31, 2022 23.43 Mn
Dec 31, 2021 20.67 Mn
Sep 30, 2021 20.98 Mn
API Access

Celldex Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=CLDX&period=max&api_key=YOUR_API_KEY